IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Endocrine-Related Cancer

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

3.66

h-Index

2022-2023

 140

Rank

2022-2023

 2877

SJR

2022-2023

 1.255

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Endocrine-Related Cancer
Abbreviation Endocr.-Relat. Cancer
Publication Type Journal
Subject Area, Categories, Scope Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1); Oncology (Q1); Cancer Research (Q2)
h-index 140
Overall Rank/Ranking 2877
SCImago Journal Rank (SJR) 1.255
Impact Score 3.66
Publisher BioScientifica Ltd.
Country United Kingdom
ISSN 13510088
Best Quartile Q1
Coverage History 1994-2022




About Endocrine-Related Cancer


Endocrine-Related Cancer is a journal covering the technologies/fields/categories related to Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1); Oncology (Q1); Cancer Research (Q2). It is published by BioScientifica Ltd.. The overall rank of Endocrine-Related Cancer is 2877. According to SCImago Journal Rank (SJR), this journal is ranked 1.255. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 140. The best quartile for this journal is Q1.

The ISSN of Endocrine-Related Cancer journal is 13510088. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Endocrine-Related Cancer is cited by a total of 1409 articles during the last 3 years (Preceding 2022).


Endocrine-Related Cancer Impact IF 2022-2023


The Impact IF 2022 of Endocrine-Related Cancer is 3.66, which is computed in 2023 as per its definition. Endocrine-Related Cancer IF is decreased by a factor of 2.14 and approximate percentage change is -36.9% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Endocrine-Related Cancer Impact IF 2023 Prediction


Impact IF 2022 of Endocrine-Related Cancer is 3.66. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Endocrine-Related Cancer. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 3.66
2021 5.80
2020 4.87
2019 4.16
2018 4.49
2017 5.07
2016 5.44
2015 4.80
2014 4.78

Endocrine-Related Cancer h-index


  Table Setting

Endocrine-Related Cancer has an h-index of 140. It means 140 articles of this journal have more than 140 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Endocrine-Related Cancer ISSN


The ISSN of Endocrine-Related Cancer is 13510088. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Endocrine-Related Cancer Rank and SCImago Journal Rank (SJR)


The overall rank of Endocrine-Related Cancer is 2877. According to SCImago Journal Rank (SJR), this journal is ranked 1.255. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Endocrine-Related Cancer by Year


Year SJR
2023/2024 Coming Soon
2022 1.255
2021 1.416
2020 1.892
2019 1.545
2018 1.985
2017 2.118
2016 2.155
2015 2.142
2014 2.254

Ranking of Endocrine-Related Cancer by Year


Year Ranking
2023/2024 Coming Soon
2022 2877
2021 2317
2020 1479
2019 2110
2018 1386
2017 1253
2016 1208
2015 1273
2014 1115

Endocrine-Related Cancer Publisher


Table Setting

Endocrine-Related Cancer is published by BioScientifica Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1994-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Endocrine-Related Cancer is Endocr.-Relat. Cancer. This abbreviation ('Endocr.-Relat. Cancer') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Endocrine-Related Cancer


If your research field is/are related to Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1); Oncology (Q1); Cancer Research (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Endocrine-Related Cancer?

Endocrine-Related Cancer latest impact IF is 3.66. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 5.80 (2021) and 3.66 (2022), respectively, in the last 9 years. Moreover, its average IS is 4.79 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Endocrine-Related Cancer?

The Endocrine-Related Cancer has an SJR (SCImago Journal Rank) of 1.255, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 2.254 in 2014 and the lowest being 1.255 in 2022. Furthermore, the average SJR of the Endocrine-Related Cancer over the previous 9-year period stands at 4.79.


What's the latest h-index of the Endocrine-Related Cancer?

The latest h-index of the Endocrine-Related Cancer is 140.


Who's the publisher of the Endocrine-Related Cancer?

The Endocrine-Related Cancer is published by the BioScientifica Ltd., with its country of publication being the United Kingdom.


What's the current ranking of the Endocrine-Related Cancer?

The Endocrine-Related Cancer is currently ranked 2877 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 1115 in 2014 and its lowest position of 2877 in 2022.


What's the abbreviation or short name for the Endocrine-Related Cancer?

The standard ISO4 abbreviation for the Endocrine-Related Cancer is Endocr.-Relat. Cancer.


Is the "Endocrine-Related Cancer" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Endocrine-Related Cancer is classified as a journal that the BioScientifica Ltd. publishes.


What's the scope or major areas of the Endocrine-Related Cancer?

The Endocrine-Related Cancer encompasses the following areas:

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Oncology
  • Cancer Research

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Endocrine-Related Cancer?

The Endocrine-Related Cancer is assigned the following International Standard Serial Numbers (ISSN): 13510088.


What's the best quartile of the Endocrine-Related Cancer?

The best quartile for the Endocrine-Related Cancer is Q1 (2022).


What's the coverage history of the Endocrine-Related Cancer?

The Endocrine-Related Cancer coverage history can be summarized as follows: 1994-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Business: Theory and Practice journal 13414 Vilnius Gediminas Technical University 21 2.47
European Union Politics journal 2250 SAGE Publications Ltd 72 2.64
Historia journal 27560 Universidade Estadual Paulista 7 0.02
Journal of Field Archaeology journal 5639 Maney Publishing 43 2.38
Clinical Medicine and Research journal 16602 Marshfield Clinic 60 1.06
Istanbul University - Journal of Electrical and Electronics Engineering journal 24654 University of Istanbul 0 0.00
Materials Research journal 14791 Universidade Federal de Sao Carlos 65 1.62
Abacus journal 8398 Wiley-Blackwell Publishing Ltd 49 2.52
Journal of Sociolinguistics journal 5409 Wiley-Blackwell Publishing Ltd 61 1.96
Sapporo Medical Journal journal 20468 Cancer Research Institute, Sapporo Medical University 3 0.00

Check complete list




Year wise Impact Score (IS) of Endocrine-Related Cancer

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 3.66
2021 5.80
2020 4.87
2019 4.16
2018 4.49
2017 5.07
2016 5.44
2015 4.80
2014 4.78



Top Journals/Conferences in Endocrinology

Lancet Diabetes and Endocrinology,The
Elsevier Ltd. | United Kingdom

Nature Reviews Endocrinology
Nature Publishing Group | United Kingdom

Endocrine Reviews
The Endocrine Society | United States

Nature Metabolism
Springer Berlin | Germany

Diabetes Care
American Diabetes Association Inc. | United States

Diabetologia
Springer Verlag | Germany

Metabolism: Clinical and Experimental
W.B. Saunders Ltd | United Kingdom

Obesity Reviews
Wiley-Blackwell Publishing Ltd | United Kingdom

Diabetes
American Diabetes Association Inc. | United States

Cytokine and Growth Factor Reviews
Elsevier BV | United Kingdom

See All

Top Journals/Conferences in Endocrinology, Diabetes and Metabolism

Lancet Diabetes and Endocrinology,The
Elsevier Ltd. | United Kingdom

Nature Reviews Endocrinology
Nature Publishing Group | United Kingdom

Endocrine Reviews
The Endocrine Society | United States

Nature Metabolism
Springer Berlin | Germany

Diabetes Care
American Diabetes Association Inc. | United States

Diabetologia
Springer Verlag | Germany

Metabolism: Clinical and Experimental
W.B. Saunders Ltd | United Kingdom

Obesity Reviews
Wiley-Blackwell Publishing Ltd | United Kingdom

Diabetes
American Diabetes Association Inc. | United States

Cytokine and Growth Factor Reviews
Elsevier BV | United Kingdom

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All